MARKET

NMRD

NMRD

Nemaura Medical Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.61
+0.09
+1.20%
Closed 16:00 07/29 EDT
OPEN
7.66
PREV CLOSE
7.52
HIGH
7.74
LOW
7.31
VOLUME
59.84K
TURNOVER
--
52 WEEK HIGH
17.40
52 WEEK LOW
3.117
MARKET CAP
177.37M
P/E (TTM)
-27.2467
1D
5D
1M
3M
1Y
5Y
Here's What Nemaura Medical Inc.'s (NASDAQ:NMRD) Shareholder Ownership Structure Looks Like
A look at the shareholders of Nemaura Medical Inc. ( NASDAQ:NMRD ) can tell us which group is most powerful...
Simply Wall St. · 4d ago
BRIEF-Nemaura Medical Inc - Under ATM Agreement, Co Offering Shares Of Its Common Stock Of Up To $100 Million
reuters.com · 6d ago
A Look at Nemaura Medical’s Risk Factors Post FY2021 Results
Nemaura Medical (NMRD) is a medical technology company focused on bringing diagnostic medical devices to the market. Its sugarBEAT is a continuous glucose monitoring device for patients with Type 1 and Type 2 diabetes. Let’s take a look at the company’s fi...
SmarterAnalyst · 07/12 12:28
Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021
Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching pr...
GlobeNewswire · 07/12 12:15
--Ascendiant Adjusts Nemaura Medical's Price Target to $17 From $15, Reiterates Buy Rating
MT Newswires · 07/12 08:47
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors thro...
ACCESSWIRE · 07/08 15:21
Nemaura Medical EPS beats by $0.02
Nemaura Medical (NMRD): FY GAAP EPS of -$0.28 beats by $0.02.As of March 31, 2021, cash on hand stood at $31.87M, compared to $0.11M as of March 31, 2020.Shares are down 1.78% PM.10KPress
Seekingalpha · 06/30 12:55
Nemaura Medical Makes Progress with Advanced Noninvasive Sensors for Diabetes Management and Metabolic Health
For millions of diabetic patients worldwide, the reality of constantly having needles pricked into the body for glucose monitoring can be a never-ending nightmare.
Benzinga · 06/22 18:39
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NMRD. Analyze the recent business situations of Nemaura Medical Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NMRD stock price target is 17.00 with a high estimate of 17.00 and a low estimate of 17.00.
EPS
Institutional Holdings
Institutions: 32
Institutional Holdings: 1.09M
% Owned: 4.67%
Shares Outstanding: 23.31M
TypeInstitutionsShares
Increased
11
150.20K
New
4
92.89K
Decreased
7
16.30K
Sold Out
6
522.29K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.52%
Healthcare Equipment & Supplies
+0.72%
Key Executives
Chairman/President/Chief Executive Officer/Director
Dewan Chowdhury
Chief Financial Officer
Justin Mclarney
Director
Bashir Timol
Independent Director
Timothy Johnson
Independent Director
Thomas Moore
Independent Director
Salim Natha
No Data
About NMRD
Nemaura Medical, Inc. is a holding company. The Company, through its subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. SugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five-minute intervals via a mobile app. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The Company’s subsidiaries include Region Green Limited.

Webull offers kinds of Nemaura Medical Inc stock information, including NASDAQ:NMRD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NMRD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NMRD stock methods without spending real money on the virtual paper trading platform.